Baylor/Texas Children's Hospital Pediatric Heart Network

贝勒/德克萨斯儿童医院儿科心脏网络

基本信息

  • 批准号:
    8692576
  • 负责人:
  • 金额:
    $ 46.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The purpose of this grant application is for Baylor College of Medicine/Texas Children's Hospital (TCH) Heart Center to become a Clinical Center of the Pediatric Heart Network sponsored by NHLBI. The goal of the PHN is to evaluate therapeutic and management strategies for children and adults with congenital heart defects and for children with inflammatory heart disease, heart muscle disease, and arrhythmias through multicenter clinical research. Baylor/TCH Heart Center has experienced multidisciplinary leadership in Cardiology, Cardiac Surgery, Cardiac Critical Care, and Cardiovascular Anesthesiology. TCH has a large patient population with diverse diagnoses undergoing over 550 open heart cases, 1000 cardiac catheterizations, 17,000 echocardiograms, and encountering more than 80 new infants with single ventricle anatomy annually. With these qualifications, Baylor/TCH Heart Center proposes to become a major contributing Clinical Center of the PHN. The clinical research protocol for this application compares regional cerebral perfusion (RCP) vs. deep hypothermic circulatory arrest (DHCA). During neonatal aortic arch reconstruction, RCP duplicates conditions achieved with DHCA, a procedure that has been associated with adverse acute and long term neurological outcomes. RCP has been widely adopted in the past decade without extensive supporting data, either in experimental animal models, or human outcomes. There is only one small single center prospective randomized controlled trial of RCP vs. DHCA, finding no difference in neurodevelopmental outcome at 1 year. The Single Ventricle Reconstruction Trial, in the same patient population, was not designed to collect neurological data or assess long term neurodevelopmental outcome. We are proposing a multicenter, prospective, randomized, controlled trial which is adequately powered, to compare early and longer term neurodevelopmental outcomes with RCP vs. DHCA. Our hypothesis is that RCP will lead to improved neurodevelopmental outcomes vs. DHCA. RELEVANCE: This large multicentered study is designed to determine the preferred method of cardiopulmonary bypass for neonatal aortic arch reconstruction. If as hypothesized, regional cerebral perfusion results in a better neurodevelopmental outcome at 18-22 months, this is expected to change practice, and improve lifelong health status for a significant portion of the approximately 9000 infants who undergo cardiac surgery in the first year of life annually in the United States.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dean B. Andropoulos其他文献

Anesthetic Management and Outcome of Complex Late Arterial-Switch Operations for Patients With Transposition of the Great Arteries and a Systemic Right Ventricle
  • DOI:
    10.1053/j.jvca.2005.03.009
  • 发表时间:
    2005-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Elif A. Akpek;Wanda C. Miller-Hance;Stephen A. Stayer;Cathy L. Rice;Debora L. East;Charles D. Fraser;E. Dean McKenzie;Dean B. Andropoulos
  • 通讯作者:
    Dean B. Andropoulos

Dean B. Andropoulos的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dean B. Andropoulos', 18)}}的其他基金

A Public-Private Partnership to support the investigation of anesthesia-related neurotoxicity in the pediatric population through non-clinical and clinical studies.
公私合作伙伴关系,通过非临床和临床研究支持儿科人群麻醉相关神经毒性的调查。
  • 批准号:
    10410115
  • 财政年份:
    2021
  • 资助金额:
    $ 46.76万
  • 项目类别:
Baylor/Texas Children's Hospital Pediatric Heart Network
贝勒/德克萨斯儿童医院儿科心脏网络
  • 批准号:
    9234738
  • 财政年份:
    2017
  • 资助金额:
    $ 46.76万
  • 项目类别:
Baylor/Texas Children's Hospital Pediatric Heart Network
贝勒/德克萨斯儿童医院儿科心脏网络
  • 批准号:
    8514058
  • 财政年份:
    2011
  • 资助金额:
    $ 46.76万
  • 项目类别:
Baylor/Texas Children's Hospital Pediatric Heart Network
贝勒/德克萨斯儿童医院儿科心脏网络
  • 批准号:
    8181942
  • 财政年份:
    2011
  • 资助金额:
    $ 46.76万
  • 项目类别:
Baylor/Texas Children's Hospital Pediatric Heart Network
贝勒/德克萨斯儿童医院儿科心脏网络
  • 批准号:
    8306750
  • 财政年份:
    2011
  • 资助金额:
    $ 46.76万
  • 项目类别:
A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED HIGH-DOSE ERYTHROPOETIN NEUROPR
一种前瞻性、随机、安慰剂对照的高剂量促红细胞生成素 NEUROPR
  • 批准号:
    8166679
  • 财政年份:
    2009
  • 资助金额:
    $ 46.76万
  • 项目类别:
A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED HIGH-DOSE ERYTHROPOETIN NEUROPR
一种前瞻性、随机、安慰剂对照的高剂量促红细胞生成素 NEUROPR
  • 批准号:
    7950626
  • 财政年份:
    2008
  • 资助金额:
    $ 46.76万
  • 项目类别:
High Dose Erythropoetin Neuroprotection Trial for Neonatal Cardiac Surgery
新生儿心脏手术的高剂量促红细胞生成素神经保护试验
  • 批准号:
    7242652
  • 财政年份:
    2007
  • 资助金额:
    $ 46.76万
  • 项目类别:
High Dose Erythropoetin Neuroprotection Trial for Neonatal Cardiac Surgery
新生儿心脏手术的高剂量促红细胞生成素神经保护试验
  • 批准号:
    7394346
  • 财政年份:
    2007
  • 资助金额:
    $ 46.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了